Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. Επικοινωνία Submitted by Στέργιος Πολύζος on Τετ, 11/13/2019 - 14:28
